These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 15605361

  • 1. Microallelotyping defines novel regions of loss of heterozygosity in uterine leiomyomas.
    Canevari Rde A, Pontes A, Rogatto SR.
    Mol Carcinog; 2005 Mar; 42(3):177-82. PubMed ID: 15605361
    [Abstract] [Full Text] [Related]

  • 2. Allelotype of uterine leiomyomas.
    Mao X, Barfoot R, Hamoudi RA, Easton DF, Flanagan AM, Stratton MR.
    Cancer Genet Cytogenet; 1999 Oct 15; 114(2):89-95. PubMed ID: 10549262
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma.
    Quade BJ, Pinto AP, Howard DR, Peters WA, Crum CP.
    Am J Pathol; 1999 Mar 15; 154(3):945-50. PubMed ID: 10079273
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The loss of heterozygosity and microsatellite instability analysis in differential diagnostics of leiomyosarcoma and proliferative leiomyoma of the uterus].
    Shikeeva AA, Kekeeva TV, Zavalishina LÉ, Andreeva IuIu, Frank GA.
    Arkh Patol; 2011 Mar 15; 73(4):47-50. PubMed ID: 22164433
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Loss of heterozygosity analysis of a candidate gastric carcinoma tumor suppressor locus at 7q31.
    Xia JC, Weng DS, Li JT, Qin HD, Mai SJ, Feng BJ, Fan Q, Feng QS, Huang LX, Yu XJ, Pan ZZ, Li YQ, Wang QJ, Zhan YQ, Chen SP, He J, Huang WL, Wu PH, Zeng YX.
    Cancer Genet Cytogenet; 2006 Apr 15; 166(2):166-72. PubMed ID: 16631475
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 19. Two discrete regions of deletion at 7q in uterine leiomyomas.
    Ishwad CS, Ferrell RE, Hanley K, Davare J, Meloni AM, Sandberg AA, Surti U.
    Genes Chromosomes Cancer; 1997 Jul 01; 19(3):156-60. PubMed ID: 9218996
    [Abstract] [Full Text] [Related]

  • 20. Mutation analysis of CDP, TP53, and KRAS in uterine leiomyomas.
    Patrikis MI, Bryan EJ, Thomas NA, Rice GE, Quinn MA, Baker MS, Campbell IG.
    Mol Carcinog; 2003 Jun 01; 37(2):61-4. PubMed ID: 12766905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.